论文部分内容阅读
采用随机分组方法 ,比较胸腺肽加卡铂 (治疗组 )与单用卡铂 (对照组 )腔内注射治疗 45例恶性胸腔积液的近期疗效。治疗组有效率 87.0 % ( 2 0 /2 3) ,对照组有效率 5 4.5 % ( 12 /2 2 ) ,两组相比差异有极显著性 (P <0 .0 1)。卡铂与胸腺肽联合治疗恶性胸腔积液疗效较好。
Randomized methods were used to compare the short-term efficacy of thymosin plus carboplatin (treatment group) and carboplatin alone (control group) in the treatment of 45 patients with malignant pleural effusion. The effective rate of the treatment group was 87.0% (20/23) and that of the control group was 54.5% (12/22). There was significant difference between the two groups (P <0.01). Carboplatin and thymosin combined treatment of malignant pleural effusion better effect.